Antiepileptic drug-induced worsening of seizures in children

Epilepsia

Volumn 39, Issue SUPPL. 3, 1998, Pages

  Guerrini, Renzo ^a,c   Belmonte, Anna ^a   Genton, Pierre ^b  

^a UNIVERSITY OF PISA   (Italy)

^b CENTRE SAINT PAUL   (France)

^c Scientific Institute of Child Neurology and Psychiatry   (Italy)

Author keywords

Antiepileptic drugs; Children; Seizure exacerbation

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

CHILD; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG OVERDOSE; ELECTROENCEPHALOGRAPHY; FREQUENCY ANALYSIS; HUMAN; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; SEIZURE;

EID: 0031897830     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb05118.x     Document Type: Conference Paper

References (57)

1. Bauer J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 1996;94:367-77.
2. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening of seizures [in press].
3. Aird RB. The importance of seizure-inducing factors in youth. Brain Dev 1988;10:73-6.
4. Ahnut H, Ashman P, Feuerstein TJ, et al. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994;35:795-801.
5. Vallarta JM, Bell DB, Reichert A. Progressive encephalopathy due to chronic hydantoin intoxication. Am J Dis Child 1974;128:27-34.
6. Osorio I, Burnstine H, Remler B, Manon-Espaillat R, Reed RC. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 1989;30:230-4.
7. Weaver DF, Camfield P, Fraser A. Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes. Neurology 1988;38:755-9.
8. Mesdjan E, Dravet C, Cenraud B, Roger J. Carbamazepine intoxication due to triacetyleolandomycin administration in epileptic patients. Epilepsia 1980;21:489-96.
9. Dhuna A, Pascual-Leone A, Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia 1991;32:275-8.
10. So EL, Ruggles KH, Cascino GD, Ahmann PA, Weatherford KW. Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide. Ann Neurol 1994;35:743-6.
11. Eeg-Olofsson O, Lindskog U. Acute intoxication with valproate. Lancet 1982;8284:1306.
12. Steiman GS, Woerpel RW. Sherard ES. Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol 1979;6:274.
13. Guerrini R, Belmonte A, Parmeggiani L, Perucca E. De novo myoclonic status epilepticus following high-dosage lamotrigine therapy in a child with Lennox-Gastaut syndrome [submitted].
14. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983;33:1487-9.
15. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986;27:706-10.
16. Holowach J, Thurston DL, O'Leary JL. Petit mal epilepsy. Pediatrics 1962;30:893-901.
17. Carter-Snead O, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-21.
18. Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986;2:340-5.
19. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994;35:1154-9.
20. Viani F, Romeo A, Viri M, et al. Seizure and EEG patterns in Angelman's syndrome. J Child Neurol 1995;10:467-71.
21. Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990;31:768-77.
22. Zimmermann FT, Burgmeister BB. A new drug for petit mal epilepsy. Neurology 1958;8:769-75.
23. Friedel B, Lempp R. Grand-mal Provokation bei der Behandlung kindlicher Petit-mal mit Oxazolidinen oder Succinimiden und ihre therapeutischen Konsequenzen. Z Kinderheilk 1962;87:42-51.
24. Lorentz De Haas AM, Kuilman M. Ethosuximide (α-ethyl-α-methylsuccinimide) and grand mal. Epilepsia 1964;5:90-6.
25. Wilder BJ, Bruni J. Barbiturates: phenobarbital, mephobarbital and metharbital. In: Wilder BJ, Bruni J, eds. Seizure disorders: a pharmacological approach to treatment. New York: Raven Press, 1981:47-60.
26. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia [in press].
27. Genton P, Dravet C, Bureau M, Formosa F, Mesdjian E. Aggravation of severe myoclonic epilepsy by lamotrigine. Epilepsia 1997;38(suppl 3):32.
28. Wakai S, Ito N, Sucoka H, Kawamoto Y, Hayasaka H, Chiba S. Severe myoclonic epilepsy in infancy and carbamazepine. Eur J Pediatr 1996;155:724.
29. Caraballo R, Fontana E, Michelizza B, et al. Carbamazepina, "assenze atipiche," "crisi atoniche" e stato di PO continua del sonno (POCS). Boll Lega It Epil 1989;66/67:379-81.
30. Guerrini R, Belmonte A, Strumia S, Hirsch E. Exacerbation of epileptic negative myoclonus by carbamazepine or phenobarbital in children with atypical benign rolandic epilepsy. Epilepsia 1995; 36(suppl 3):S65.
31. Guerrini R, Dravet C, Genton P, et al. Epileptic negative myoclonus. Neurology 1993;43:1078-83.
32. Martin D. Intravenous nitrazepam in the treatment of epilepsy. Neuropediatrie 1970;2:27-37.
33. Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H. Tonic status epilepticus precipitated by intravenous benzodiazepines in five patients with Lennox-Gastaut syndrome. Epilepsia 1972;13:421-35.
34. Prior PF, Maclaine GN, Scott DF, Laurance BM. Tonic status epilepticus precipitated by intravenous diazepam in a child with petit mal status. Epilepsia 1972;13:467-72.
35. Waltregny A, Dargent J. Preliminary study of parenteral lorazepam in status epilepticus. Acta Neurol Belg 1975;75:219-29.
36. Amand G, Evrard P. Le lorazepam injectable dans les etats de mal epileptiques. Rev EEG Neurophysiol Clin 1976;6:532-3.
37. Bittencourt PRM, Richens A. Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome. Epilepsia 1981;22:129-34.
38. Di Mario FJ Jr, Calancy RR. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 1988;4:249-51.
39. Papini M, Pasquinelli A, Armellini M, Orlandi D. Alertness and incidence of seizures in patients with Lennox-Gastaut syndrome. Epilepsia 1984;25:161-7.
40. Ohtsuka Y, Yoshida H, Miyaka S, et al. Induced microseizures: clinical and electroencephalographic study. In: Akimoto H, Kazamatsuri H, Seino M, Ward A, eds. Advances in epileptology. XIIIth Epilepsy International Symposium. New York: Raven Press, 1982:33-5.
41. Ohtahara S, Ohtsuka Y, Miyaka S, et al. Induced microseizures: clinical and electroencephalographic study. Tenkan Kenkvu (Tokyo) 1983;1:51-60.
42. Sano N, Nagao H, Morimoto T, Takahashi M, Habara S, Matsuda H. A case of West syndrome which presented induced microseizures. Rinsho Noha (Osaka) 1984;26:541-2.
43. Ichiyama T, Hayashi T, Tateishi H, Tanaka H. ACTH-induced tonic seizures. The influence of clonazepam on the induction of seizures. Rinsho Noha (Osaka) 1990;32:410-2.
44. Otani K, Tagawa T, Futagi Y, Okamoto N, Yabuuchi H. Induced microseizures in West syndrome. Brain Dev 1991;13:196-9.
45. Alvarez N, Hartford E, Doubt C. Epileptic seizures induced by clonazepam. Clin Electroencephalogr 1981;12:57-65.
46. Lortie A, Chiron C, Mumford J, Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993;43(suppl 5):S24-7.
47. Marciani MG, Maschio M, Spanedda F, Iani C, Gigli GL, Bernardi G. Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study. Acta Neurol Scand 1995;91:1-5.
48. Vossler DG. Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. Neurology 1996;46:852-3.
49. Trudeau V, Myers S, LaMoreaux L, Ahnut H, Garofalo E, Ebersole J. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996;11:470-5.
50. Asconap J, Diedrich A, DellaBadia J. Gabapentin-associated myoclonus. Neurology 1995;45(suppl 4):A249-50.
51. Scheyer RD, Assaf BA, Spencer SS, Mattson RH. Gabapentin related myoclonus. Epilepsia 1996;37(suppl 5):203.
52. Kanayama M, Ishikawa T, Tauchi A, Kobayashi M, Takasaka Y, Shibata H. ACTH-induced seizures in an infant with West syndrome. Brain Dev 1989;11:329-31.
53. Dreifuss FE, Santilli N, Langer DH, Sweeny KP, Moline BA, Menander KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37:379-85.
54. Kšnig SA, Siemes H, Blaker F, et al. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 1994;35:1005-15.
55. Dreifuss FE, Langer DH, Moline A, Maxwell E. Valproic acid fatalities. II. US experience since 1984. Neurology 1989;39:201-7.
56. Salke-Kellermann A, Baier H, Rambeck B, Boenigk HE, Wolf P. Acute encephalopathy with vigabatrin. Lancet 1993;342:185.
57. Genton P, Guerrini R, Roger J. Treatment of epilepsy in children and adults with multiple handicaps. In: Shorvon S, Dreifuss F, Fish D, Thomas D, eds. The treatment of epilepsy. London: Blackwell Science, 1996:215-26.